Back to 
Stifel Financial Corp.
Stifel Financial Corp.
ARWR
Showing 3 of 21 quarters
Position history for Stifel Financial Corp.'s holdings in Arrowhead Pharmaceuticals, Inc.
Yes. Stifel Financial holds 73,294 shares of ARWR (Arrowhead Pharmaceuticals), worth $6M, as of its Q2 2026 13F filing. It increased the position from 11,696 shares in Q1 2026. Stifel Financial has held ARWR since Q4 2025, across 3 quarterly 13F filings.
Current Value
$6M
Current Shares
73,294
Total Value Change
+$5.2M
Total Shares Change
+61,483
Quarter-by-Quarter History